Publications & Presentationsbreadcrumb separatorPublicationsbreadcrumb separatorClinicalbreadcrumb separator2018
Clinical Publications 2018

1 Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens. A Cozzi-Lepri, R Zangerle, L Machala, K Zilmer, M Ristola, C Pradier, O Kirk, J Grarup, H Sambatakou, G Fätkenheuer, I Yust, P Schmid, M Gottfredsson, I Khromova, D Jilich , R Flisiak, J Smidt, B Rozentale, R Radoi, MH Losso, JD Lundgren, A Mocroft on behalf of EuroSIDA.
HIV Med. 2018;19(2):102-117. abstract

2 Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study. A.M. W. Efsen, A. Schultze, R.F. Miller, A. Panteleev, A. Skrahin, D.N. Podlekareva, J.M. Miro, E. Girardi, H. Furrer, M.H. Losso, J. Toibaro, J. A. Caylà, A. Mocroft, J.D. Lundgren, F.A. Post, O. Kirk, for the TB:HIV study in EuroCoord.
J Infect. 2018;76(1):44-54. Abstract

3 The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people. Shepherd L, Borges ÁH, Harvey R, Bower M, Grulich A, Silverberg M, Weber J, Ristola M, Viard JP, Bogner JR, Gargalianos-Kakolyris P, Mussini C, Mansinho K, Yust I, Paduta D, Jilich D, Smiatacz T, Radoi R, Tomazic J, Plomgaard P, Frikke-Schmidt R, Lundgren J, Mocroft A for EuroSIDA in EuroCOORD.
HIV Med. 2018;19(2):90-101. Abstract 

4 Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV? A Mocroft, K Laut, P Reiss, J Gatell, V Ormaasen, M Cavassini, V Hadziosmanovic, K Mansinho, C Pradier, M Vasylyev, V Mitsura, L Vandekerckhove, L Ostergaard, A Clarke, O Degen, F Mulcahy, A Castagna, Z Sthoeger, L Flamholc, D Sedláček, I Mozer-Lisewska, JD Lundgren for the EuroSIDA study.
AIDS. 2018;32(2):205-215. Abstract

5 Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis.  P Schuetz, Y Wirz, R Sager, M Christ-Crain, D Stolz, M Tamm, L Bouadma, CE Luyt, M Wolff, J Chastre, F Tubach, K Kristoffersen, O Burkhardt, T Welte, S Schroeder, V Nobre, L Wei, HC Bucher, D Annane, K Reinhart, AR Falsey, A Branche, P Damas, M Nijsten, DW de Lange, RO Deliberato, CF Oliveira, V Maravić-Stojković, A Verduri, B Beghé, B Cao, Y Shehabi, JS Jensen, C Corti, JAH van Oers, A Beishuizen, ARJ Girbes, E de Jong, M Briel, B Mueller.
Lancet Infect Dis. 2018;18(1):95-107. Abstract

6 Abacavir use and risk of recurrent myocardial infarction.Sabin CA, Ryom L, d'Arminio Monforte A, Hatleberg CI, Pradier C, El-Sadr W, Kirk O, Weber R, Phillips AN, Mocroft A, Bonnet F, Law M, de Wit S, Reiss P, Lundgren JD; D:A:D Study Group.
AIDS. 2018;32(1):79-88. Abstract

7 Abacavir Usage Patterns and Hypersensitivity Reactions (HSR) in the EuroSIDA cohort. A Roen, K Laut, A Pelchen-Matthews, E Borodulina, L Caldeira, A Clarke, B Clotet, A d'Arminio Monforte, G Fätkenheuer, JM. Gatell Artigas, IKarpov, A Kuznetsova, G Kyselyova, I Mozer-Lisewska, F Mulcahy, L Ragone, A Scherrer, V Uzdaviniene, L Vandekerckhove, V Vannappagari, L Ostergaard, A Mocroft for the EuroSIDA study
HIV Med. 2018;19(4):252-260. Abstract

8 Long-term Effectiveness of Recommended Boosted PI-Based Antiretroviral Therapy in Europe. Santos JR, Cozzi-Lepri A, Phillips A, De Wit S, Pedersen C, Reiss P, Blaxhult A, Lazzarin A, Sluzhynska M, Orkin C, Duvivier C, Bogner J, Gargalianos-Kakolyris P, Schmid P, Hassoun G, Khromova I, Beniowski M, Hadziosmanovic V, Sedlacek D, Parades R, Lundgren JD for the EuroSIDA study. 
HIV Med. 2018;19(5):324-338. Abstract

9 Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study.  Hatleberg CI,  Ryom L,  El-Sadr W,  Mocroft A, Reiss P, De Wit S, Dabis F, Pradier C, d’Arminio Monforte A, Kovari H, Law, M, Lundgren JD, Sabin C, On behalf of the Data Collection of Adverse Events of Anti-HIV drugs (D:A:D) Study group.
J Int AIDS Soc. 2018;21(3). Abstract

10 Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015. Laut KG, Shepherd L, Radoi R, Karpov I, Parczewski M, Mussini C, Maltez F, Losso M, Chkhartishvili N, Elinav H, Kovari H, Blaxhult A, Zangerle R, Trofimora T, Knysz B, Zilmer K, Kouzovatova E, Staub T, Raben D, Lundgren JD, Mocroft A, Kirk O for the EuroSIDA study.
Eurosurveillance 2018  Volume 23, Issue 21. Article 

11 The association between detected drug resistance mutations and CD4+ T-cell decline in HIV-positive individuals maintained on a failing treatment regimen. A Schultze, R Paredes, C Sabin, AN Phillips, D Pillay, N Mackie, A Castagna, D Chadwick, K Falconer, AM Geretti, FA Post, T Hill, O Kirk, A Pozniak, M Nelson, A Tostevin, D Dunn, J Lundgren, A Cozzi-Lepri.
Persistent dispAntivir Ther. 2018;23(2):105-116.  Abstract 

12 Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study. L Ryom, JD Lundgren, W El-Sadr, P Reiss, O Kirk, M Law, A Phillips, R Weber, E Fontas, A d’ Arminio Monforte, S de Wit, F Dabis, CI Hatleberg, C Sabin, A Mocroft. On behalf of the D:A:D Study group
Lancet HIV. 2018 Jun;5(6):e291-e300.  Abstract

13 Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation.
IP Lodding , C da Cunha Bang, SS Sørensen, F Gustafsson, M Iversen, N Kirkby, M Perch, A Rasmussen, H Sengeløv, A Mocroft, JD Lundgren.
Open Forum Infect Dis. 2018;5(5) Abstract

14  Cytomegalovirus Viral Load in Bronchoalveolar Lavage to Diagnose Lung Transplant Associated CMV Pneumonia. IP Lodding, HH Schultz, JU Jensen , N Kirkby, M Perch, C Andersen, JD Lundgren , M Iversen.
Transplantation, 2018; 102(2):326-332. Abstract

15  The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients. NE Wareham , A Mocroft, H Sengeløv, C Da Cunha-Bang, F Gustafsson, C Heilmann, M Iversen, NS Kirkby, A Rasmussen, SS Sørensen, JD Lundgren; MATCH in PERSIMUNE study group.
J Cancer Res Clin Oncol. 2018. Abstract

16 Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic. L Simonsen, E Higgs , RJ Taylor, D Wentworth, A Cozzi-Lepri, S Pett, DE Dwyer, R Davey, R Lynfield, M Losso, K Morales, MJ Glesby, J Weckx, D Carey, C Lane, J Lundgren; INSIGHT FLU002 and FLU003 Study Groups.
Clin Infect Dis. 2018. Abstract

17 Differences in virological and immunological risk factors for non-Hodgkin and Hodgkin lymphoma.
L Shepherd, L Ryom, M Law, C Ingrid Hatleberg, S de Wit, A d'Arminio Monforte, M Battegay, A Phillips, F Bonnet, P Reiss, C Pradier, A Grulich, C Sabin, J Lundgren, A Mocroft,
J Natl Cancer Inst. 2018;110(6):598-607.  Abstract

18 Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the D:A:D Study. CI Hatleberg, L Ryom, A d’Arminio Monforte, E Fontas, P Reiss, O Kirk, W El-Sadr, A Phillips, S de Wit, F Dabis, R Weber, M Law, JD Lundgren, C Sabin  On behalf of the Data collection of Adverse events of anti-HIV Drugs (D:A:D) Study Group
HIV Med. 2018;19(9):605-618. Epub 2018 Jul 18. Abstract

19 Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation. IP Lodding, A Mocroft, C da Cunha Bang, F Gustafsson, M Iversen, N Kirkby, M Perch, A Rasmussen, H Sengeløv, S Sørensen, JD Lundgren.
Transplant Direct. 2018 May 16;4(6):e355. Abstract

20 Associations between serum albumin and serious non-AIDS events among people living with HIV. A Ronit, CI Hatleberg, L Ryom, F Bonnet, W El-Sadr, P Reiss, R Weber, C Pradier, S De Witt, M Law, A d’Arminio Monforte, J Lundgren, A Mocroft, AN Phillips, C Sabin, for the D:A:D Study group
AIDS. 2018;32(13):1837-1848.  Abstract

21 Body Mass Index and the Risk of serious non-AIDS events and all cause mortality in treated HIV-positive individuals: D:A:D Cohort Analysis
AC Achhra, C Sabin, L Ryom, C Hatleberg, A d’Aminio Monforte, S de Wit, A Phillips, C Pradier, R Weber, P Reiss, W El-Sadr, F Bonnet, A Mocroft, J Lundgren, MG Law for the D:A:D study group
J Acquir Immune Defic Syndr. 2018;78(5):579-588.  Abstract

22 Airflow limitation in people living with HIV and matched uninfected controls. Ronit A, Lundgren J, Afzal S, Benfield T, Roen A, Mocroft A, Gerstoft J, Nordestgaard BG, Vestbo J, Nielsen SD; Copenhagen Co-morbidity in HIV infection (COCOMO) study group.
Thorax. 2018;73(5):431-438.  Epub 2018 Jan 13. Abstract

23 Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals. L Peters, K Laut, C Resnati, S Del Campo, C Leen, K Falconer, T Trofimova, D Paduta, J Gatell, A Rauch, K Lacombe, P Domingo, N Chkhartishvili, R Zangerle, R Matulionyte, V Mitsura, T Benfield, K Zilmer. I Khromova, J Lundgren, J Rockstroh, A Mocroft for the EuroSIDA study. 
AIDS. 2018;32(14):1995-2004. Abstract 

24 Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort. A Pelchen-Matthews, L Ryom, A Borges, S Edwards, C Duvivier, C Stefan, H Sambatakou, K Maciejewska, J Joaquín Portu, J Weber, O Degen, A Calmy, DH Reikvam, D Jevtovic, L Wiese, J Smidt, T Smiatacz, G Hassoun, A Kuznetsova, B Clotet, J Lundgren, A Mocroft for the EuroSIDA study.
AIDS. 2018;32(16):2405-2416.  Abstract

25 Febrile Neutropenia and Long-term Risk of Infection Among Patients Treated With Chemotherapy for Malignant Diseases.
Nordvig J, Aagaard T, Daugaard G, Brown P, Sengeløv H, Lundgren J, Helleberg M.
Open Forum Infect Dis. 2018 5(10)  Abstract

26 Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study. Peters L, Mocroft A. Grint D, Moreno S, Calmy A, Jevtovic D, Sambatakou H, Lacombe K, De Wit S, Rockstroh J, Smidt J, Karpov I, Grzeszczuk A, Haziosmanovic V, Gottfredsson M, Radoi R, Kuzovatova E, Orkin C, Ridolfo AL, Zapirain J, Lundgren J for the EuroSIDA study.
Antivir Ther. 2018;23(5):405-413. Abstract

27 Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations. K Laut, L Shepherd, M Gottfredsson, D Sedlacek, B Knysz, J Begovac, R Radoi, B Schmied, N Chkhartishvili, E Florence, M Ristola, G Fätkenheuer, F Mulcahy, P Schmid, E Kuzovatova, D Paduta, J Smidt, P Domingo, J Szlávik,  J Lundgren, A Mocroft, O Kirk on behalf of the EuroSIDA study group
AIDS. 2018;32(18):2807-2819. Abstract 

28 Smoking and accelerated lung function decline in HIV-positive individuals: a secondary analysis of the START Pulmonary Substudy. MacDonald DM, Melzer AC, Collins G, Avihingsanon A, Crothers K, Ingraham NE, Mugerwa H, Ristola M, Shuter J, and Kunisaki KM for the INSIGHT START Pulmonary Substudy Group.
J Acquir Immune Defic Syndr 2018; 79(3):e85-e92. Abstract

29 Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America. Caro-Vega, A. Schultze, A.M. W. Efsen, F.A. Post, A. Panteleev, A. Skrahin, J.M. Miro, E. Girardi, D.N. Podlekareva, J.D. Lundgren, j. Sierra-Madero, J. Toibaro, J. Andrade-Villanueva, S. Tetradov, J. Fehr, J. Caylà, M.H. Losso, R.F. Miller, A. Mocroft, O. Kirk, B. Crabtree-Ramírez. 
BMC Infect Dis. 2018;18(1):191. Abstract